AB 1561 defines “complex rehabilitation technology” and “complex needs patient” for Medi‑Cal, then prescribes enrollment, accreditation, staffing, evaluation, and recordkeeping requirements for suppliers who provide that equipment. It also lets the Department of Health Care Services (DHCS) adopt utilization controls but forbids prior authorization for repairs to powered CRT wheelchairs that cost $1,250 or less and relaxes practitioner documentation for repairs/replacements of already‑approved equipment.
The bill matters because it ties supplier standards to federal Medicare DME rules, mandates specific credentials and W‑2 employment for rehabilitation technology professionals, and changes preauthorization and audit mechanics for repairs — a package that will affect access for high‑need beneficiaries, compliance work for suppliers, and DHCS’s oversight and audit workload. Implementation is conditioned on obtaining any required federal approvals and available federal financial participation.
At a Glance
What It Does
AB 1561 creates a statutory definition of complex rehabilitation technology tied to Medicare DME classifications as of January 1, 2021, and requires Medi‑Cal suppliers to meet Medicare supplier and DME standards, obtain accreditation, and employ credentialed rehabilitation technology professionals. It authorizes DHCS to adopt utilization controls but bars prior authorization for powered wheelchair repairs costing $1,250 or less and removes the need for a new treating‑practitioner prescription for repairs or replacements of previously approved CRT wheelchairs.
Who It Affects
The bill affects Medi‑Cal beneficiaries with significant mobility‑related impairments, durable medical equipment (DME) and complex rehab technology (CRT) suppliers, credentialed rehabilitation technology professionals, treating clinicians who certify medical necessity, and DHCS and Medi‑Cal managed care plans responsible for coverage and audits.
Why It Matters
By codifying supplier accreditation, personnel and documentation standards and narrowing prior‑auth rules for common repairs, the bill aims to speed repairs and replacements for high‑need patients while shifting compliance burdens onto suppliers and DHCS. Employers and compliance officers in the DME/CRT supply chain will need to change hiring, recordkeeping, and billing practices.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
AB 1561 first draws a clear line around who and what qualify: it defines a “complex needs patient” by listing diagnoses and types of impairment and anchors “complex rehabilitation technology” to items that Medicare treated as DME on January 1, 2021. That anchoring matters because it fixes the scope of covered devices to a federal snapshot rather than an open‑ended list, and it makes many implementations and interpretations dependent on that Medicare classification.
The bill requires any supplier who provides CRT to enroll in Medi‑Cal and meet federal Medicare durable medical equipment supplier and quality standards, and to obtain accreditation specifically recognized for supplying complex rehabilitation technology. Each distribution location must employ at least one qualified rehabilitation technology professional as a W‑2 employee; the bill names two acceptable credentials (ATP and CRTS) and allows DHCS to approve other credentials.
Suppliers must maintain parts inventories, repair capacity, adequate facilities, and provide written repair/service information to patients at delivery.For clinical decisions the bill mandates dual expertise: complex needs patients receiving manual or power wheelchairs or seating components must be evaluated by both a qualified health care professional (for example, a licensed PT or OT, or another DHCS‑approved clinician) and a qualified rehabilitation technology professional. A treating medical provider must conduct a physical exam and complete a certificate of medical necessity before prescribing a power wheelchair or scooter, verifying both medical need and the patient’s capacity to use the device safely.
The statute permits these evaluations and exams to occur remotely where necessary.On utilization management, DHCS can adopt controls, including specialty evaluations, but the bill limits prior authorization for CRT‑powered wheelchair repairs: repairs with a cost of $1,250 or less do not require prior authorization. Once a CRT‑powered wheelchair has been approved and recorded with the Medi‑Cal program, suppliers do not need a new practitioner prescription or documentation of medical necessity for subsequent repairs or replacements, though suppliers must keep repair records and make them available for postpayment audit.
If a wheelchair is not already on file, suppliers must record the equipment and demonstrate continuous medical need before relying on the streamlined repair pathway. Finally, implementation is subject to obtaining necessary federal approvals and federal financial participation.
The Five Things You Need to Know
AB 1561 fixes the universe of covered CRT items to what Medicare classified as durable medical equipment on January 1, 2021.
Each supplier distribution location must employ at least one qualified rehabilitation technology professional as a W‑2 employee; acceptable credentials explicitly include ATP and CRTS.
DHCS cannot require prior authorization for repairs to CRT‑powered wheelchairs if the repair cost is $1,250 or less.
For repairs or replacements of a CRT‑powered wheelchair already approved and recorded for the patient, suppliers do not need a new treating‑practitioner prescription or new medical necessity documentation, but must retain repair documentation subject to postpayment audit.
A treating medical provider must perform a physical examination and complete a certificate of medical necessity verifying safe use before prescribing a power wheelchair or scooter.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Definitions — ‘complex needs patient’ and ‘complex rehabilitation technology'
This subsection defines the covered population and devices. ‘‘Complex needs patient’’ is described by diagnosis categories and functional limitations and explicitly preserves the requirement that medical necessity still be met. ‘‘Complex rehabilitation technology’’ is tethered to Medicare’s DME classification as of January 1, 2021, and lists example device types (complex manual and power wheelchairs, seating and positioning systems, standing frames, gait trainers, etc.). The Medicare‑anchoring limits statutory ambiguity but also freezes the covered device set to a historical federal snapshot unless the statute or implementing regulations say otherwise.
Qualified personnel — health care and rehabilitation technology professionals
The bill separates clinical evaluators (qualified health care professionals such as licensed PTs and OTs or DHCS‑approved clinicians) from technical experts (qualified rehabilitation technology professionals). It specifies credential paths for the technical role — ATP and CRTS — and allows DHCS to approve others. This dual‑role approach formalizes who can make clinical determinations versus who must design and fit equipment, with the practical effect of elevating the professional qualifications suppliers must have on staff or under contract.
Supplier enrollment, accreditation, staffing, and service obligations
Suppliers must enroll in Medi‑Cal, meet federal Medicare DME supplier and quality standards, and be accredited by a recognized accreditor for supplying CRT. Each distribution location must employ at least one qualified rehabilitation technology professional as a W‑2 employee; suppliers must stock parts, maintain repair capability, and provide prompt service. The provision shifts operational, capital, and human‑resources obligations onto suppliers and creates a clear compliance baseline DHCS can inspect or audit.
Dual evaluations and certificate of medical necessity for powered mobility
For complex needs patients getting a manual or power wheelchair or seating components, the bill requires evaluation by both a qualified health care professional and a qualified rehabilitation technology professional, in person or remotely. Before prescribing a power wheelchair or scooter, a medical provider must conduct a physical exam and complete a certificate of medical necessity confirming the condition and safe use. These mechanics aim to reduce inappropriate prescriptions while allowing remote options, but they also create additional touchpoints and documentation steps for clinicians and suppliers.
Utilization controls and repair authorization rules
DHCS may adopt utilization controls, including specialty evaluations, but the bill limits prior authorization for repairs to CRT‑powered wheelchairs at or below $1,250. For repairs or replacement of already‑approved CRT‑powered wheelchairs, suppliers need not obtain a new treating‑practitioner prescription or new medical necessity documentation, but they must document details of repairs and retain records for postpayment audits. If a wheelchair is not on file with Medi‑Cal, the supplier must first record the equipment and demonstrate continuous medical need. This subsection balances streamlined repair access against recordkeeping and audit trails.
Federal approval condition
The statute requires DHCS to seek any necessary federal approvals and conditions implementation on securing federal financial participation and approvals. That makes practical implementation contingent on CMS sign‑off where federal Medicaid rules intersect, and it gives DHCS a regulatory lever to interpret or phase in the statute in line with federal requirements.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Complex needs Medi‑Cal beneficiaries — Faster access to repairs and replacements for CRT‑powered wheelchairs when repairs cost $1,250 or less and when equipment has an existing Medi‑Cal approval reduces downtime for mobility devices.
- Accredited CRT suppliers with credentialed staff — Suppliers that already meet Medicare DME standards and employ ATP/CRTS professionals gain a clearer compliance advantage and may capture more referrals because the law privileges accredited, credentialed providers.
- Qualified rehabilitation technology professionals — The statute elevates the technical role (ATP/CRTS) by requiring W‑2 employment per distribution location, increasing demand for those credentials and formalizing their role in evaluations and fittings.
Who Bears the Cost
- Smaller or non‑accredited CRT suppliers — They face added costs to obtain accreditation, hire W‑2 credentialed staff at each location, expand parts inventories, and upgrade facilities, which may force consolidation or exit from the Medi‑Cal CRT market.
- Department of Health Care Services (DHCS) and state oversight bodies — DHCS must develop regulations, approve additional credentials, manage implementation, process federal approval requests, and handle an increased audit workload from postpayment reviews.
- Treating clinicians and medical practices — Providers must perform physical exams and complete certificates of medical necessity before prescribing powered mobility devices, adding documentation time and possible liability for verifying safe use.
Key Issues
The Core Tension
The central tension is access versus program integrity: the bill speeds repairs and reduces up‑front authorization friction for beneficiaries in urgent need, but it compensates by imposing tougher supplier accreditation, staffing, documentation, and postpayment audit requirements — a trade‑off between faster service today and higher compliance and oversight costs tomorrow.
AB 1561 attempts to thread two competing policy goals: expand timely access to repairs and replacements for highly dependent beneficiaries while preserving program integrity through accreditation, credentialing, documentation, and audits. The $1,250 prior‑auth floor accelerates common repairs but raises questions about potential overutilization or fraud; DHCS’s answer is postpayment audits, which shift the burden from prospective review to retrospective enforcement and can create cash‑flow and administrative stress for suppliers and the department.
Operational definitions and delegated discretion matter here. The bill anchors CRT to Medicare’s January 1, 2021 DME classifications and lists example devices, but it leaves room for implementation choices — which accrediting organizations qualify, what other credentials DHCS will accept, and what counts as ‘‘proof of continuous medical need’’ when a wheelchair is first recorded.
The W‑2 employment requirement at each distribution location protects quality but may be impractical for rural suppliers or models that rely on contracted clinicians; that could narrow provider networks and reduce competition. Finally, making implementation conditional on federal approval is sensible legally but creates uncertainty and possible delays; if CMS imposes conditions, the statute’s practical effect could differ materially from its text.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.